Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study - 14/03/18
Funding sources: None. |
|
Disclosure: Dr Yeung has been a speaker and/or consultant and/or investigator for AbbVie, Allergan, Amgen, Astellas, Boehringer Ingelheim, Celgene, Centocor, Coherus, Dermira, Eli Lilly, Forward, Galderma, Janssen, Leo, Medimmune, Merck, Novartis, Pfizer, Regeneron, and Takeda. Dr Shear has been a consultant and/or speaker for AbbVie, Actelion, Amgen, Celgene, Hospira, Janssen, Janssen Biotech, Lilly, Novartis, Sanofi, Genzyme, and Takeda. Dr Walsh has been a consultant for AbbVie, Amgen, Celgene, Janssen, and Lilly. Mr Georgakopoulos and Mr Ighani have no conflicts of interest to disclosed. |
|
Reprints not available from the authors. |
Vol 78 - N° 4
P. 801-803 - avril 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?